Potentially inappropriate prescribing and cost outcomes for older people: a national population study - PubMed (original) (raw)

Potentially inappropriate prescribing and cost outcomes for older people: a national population study

Caitriona Cahir et al. Br J Clin Pharmacol. 2010 May.

Abstract

Aims: Optimization of drug prescribing in older populations is a priority due to the significant clinical and economic costs of drug-related illness. This study aimed to: (i) estimate the prevalence of potentially inappropriate prescribing (PIP) in a national Irish older population using European specific explicit prescribing criteria; (ii) investigate the association between PIP, number of drug classes, gender and age and; (iii) establish the total cost of PIP.

Methods: This was a retrospective national population study (n= 338 801) using the Health Service Executive Primary Care Reimbursement Service (HSE-PCRS) pharmacy claims database. The HSE-PCRS uses the WHO Anatomical Therapeutic Chemical (ATC) classification system and details of every drug dispensed and claimants' demographic data are available. Thirty PIP indicators (STOPP) were applied to prescription claims for those >or=70 years in Ireland in 2007. STOPP is a physiological system based screening tool of older persons' potentially inappropriate prescriptions assessing drug-drug and drug-disease interactions, dose and duration.

Results: In our study population PIP prevalence was 36% (121 454 claimants). The main contributors to this were: 56 560 (17%) prescribed proton pump inhibitors at maximum therapeutic dose for >8 weeks, 29 691 (9%) prescribed non-steroidal anti-inflammatories for >3 months, 17 676 (5%) prescribed long-acting benzodiazepines for >1 month and 16 201 (5%) prescribed duplicate drugs. The main determinant of PIP was polypharmacy. The likelihood of PIP increased with a significant linear and quadratic trend (P < 0.0001) with the number of drug classes.The maximum net ingredient cost of PIP was estimated to be euro38 664 640. Total PIP expenditure was estimated to be euro45 631 319, 9% of the overall expenditure on pharmaceuticals in those >or=70 years in 2007.

Conclusions: The findings identify a high prevalence of PIP in Ireland with significant cost consequences.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Duration and dosage of PPI therapy for a 1 year continuous period in patients aged ≥70 years on PPI therapy for >8 weeks at maximum therapeutic dosage. 1 year period- January 2007 to January 2008, February 2007 to February 2008. Dosage is the dose at the end of each month. Maximum therapeutic dose = 40 mg daily omeprazole, pantoprazole and esomeprazole, 30 mg daily lansoprazole and 20 mg daily rabeprazole. Maintenance therapeutic dose = 10–20 mg daily omeprazole, 20 mg daily pantoprazole and esomeprazole, 15 mg daily lansoprazole and 10 mg daily rabeprazole. Maintenance dosage (formula image); Maximum dosage (formula image)

Figure 2

Figure 2

The association between polypharmacy and PIP in 2007. Repeat prescriptions (minimum of three per year). Odds ratio = odds ratio of any potentially inappropriate drug adjusted for gender and age (reference = 0)

Similar articles

Cited by

References

    1. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2007;63:177–86. - PMC - PubMed
    1. Lau DT, Kasper JD, Potter DEB, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165:68–74. - PubMed
    1. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84. - PubMed
    1. O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37:138–41. - PubMed
    1. Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994;47:891–6. - PubMed

Publication types

MeSH terms

LinkOut - more resources